Orwin John A

CIK 00014773846 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001477384

Recent Transactions

22 trades

Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2024-09-15+1,300→ 3,335 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2024-09-15−1,300→ 2,600 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2024-06-15−2,035→ 0 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2024-06-15+2,035→ 2,035 total
Award
CARGO Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-04+23,742→ 23,742 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-05-08+6,500→ 28,875 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2024-05-08+19,500→ 19,500 total
Purchase
Atreca, Inc.
Series A Junior Preferred Stock
2024-04-11$0.01/sh+1→ 1 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2024-01-03+6,030→ 6,030 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2024-01-03+16,510→ 16,510 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2023-09-15+10,600→ 10,600 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2023-09-15+3,900→ 3,900 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2023-09-15+2,035→ 2,035 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2023-09-15+3,311→ 3,311 total
Sale
Atreca, Inc.
Class A Common Stock
2023-09-01$0.37/sh−22,951→ 77,541 total
Award
Atreca, Inc.
Employee stock option (right to buy)
2023-02-09+435,000→ 435,000 total
Exercise/Conversion
AFFYMAX INC
Stock Option (Right to Buy)
2012-08-20−11,500→ 57,000 total
Exercise/Conversion
AFFYMAX INC
Common Stock
2012-08-20$5.83/sh+11,500→ 103,500 total
Sale
AFFYMAX INC
Common Stock
2012-08-20$17.50/sh−48,996→ 92,000 total
Exercise/Conversion
AFFYMAX INC
Stock Option (Right to Buy)
2012-08-20−37,496→ 262,504 total
Exercise/Conversion
AFFYMAX INC
Common Stock
2012-08-20$6.90/sh+37,496→ 140,996 total
Award
NeurogesX Inc
Nonstatutory stock option (right to buy)
2011-06-02+10,000→ 10,000 total

Companies

Recent Filings

Address

C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DR., SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov